Physician profile
Eric Ray Rittenhouse
NPI 1376520593
$6,430.86
in general payments reported to CMS, 2019-2025
42 companies · $617 in 2025
The $617 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $622 · 2020: $645 · 2021: $1,880 · 2022: $872 · 2023: $926 · 2024: $869 · 2025: $617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,326 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,326.33 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,107.07 | 2020-2023 | Axonics, Bulkamid |
| Abbvie INC. | $1,005.35 | 2019-2025 | Lo Loestrin Fe, Orilissa |
| Astellas Pharma US INC | $922.68 | 2019-2024 | Veozah, Myrbetriq |
| Pfizer INC. | $569.73 | 2019-2025 | |
| Sage Therapeutics, LLC | $324.22 | 2024-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $257.10 | 2023-2025 | Gemtesa, Myfembree |
| Mayne Pharma Commercial LLC | $236.38 | 2022-2025 | |
| Myovant Sciences INC. | $174.28 | 2021-2022 | |
| Organon LLC | $163.30 | 2021-2024 | Nexplanon |
| Daiichi Sankyo INC. | $153.31 | 2020-2022 | |
| Lilly USA, LLC | $146.08 | 2024-2025 | Zepbound |
| Femselect INC. | $104.94 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $102.81 | 2020-2025 | |
| Mylan Pharmaceuticals INC. | $96.35 | 2020-2022 | |
| Therapeuticsmd, INC. | $86.71 | 2019-2020 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $85.54 | 2019-2021 | |
| Novo Nordisk INC | $80.80 | 2023-2024 | Wegovy |
| Millicent US INC | $80.02 | 2019-2025 | Femlyv, Intrarosa |
| Shield Therapeutics INC | $77.67 | 2023 | Accrufer |
| Boston Scientific Corporation | $73.95 | 2019-2023 | |
| Exeltis, USA INC. | $49.35 | 2021-2022 | |
| Amgen INC. | $49.32 | 2024 | Prolia, Evenity |
| Alexion Pharmaceuticals, INC. | $46.53 | 2023 | Ultomiris |
| Ethicon US, LLC | $39.32 | 2021-2024 | Harmonic, Stratafix, Echelon; Endopath |
| Hologic Sales and Service, LLC | $38.65 | 2019-2024 | Myosure Tissue Removal Device, Fluent Fluid Management System |
| Medtronic, INC. | $36.34 | 2021-2022 | |
| Minerva Surgical, INC | $33.94 | 2021-2024 | |
| Allergan, INC. | $31.70 | 2020 | |
| Smith+Nephew, INC. | $27.46 | 2019-2020 | |
| Sanofi Pasteur INC. | $24.34 | 2024 | |
| Aspira Women'S Health INC | $22.93 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $22.58 | 2023 | Gattex |
| Urovant Sciences INC | $18.58 | 2022 | |
| Supernus Pharmaceuticals, INC. | $18.17 | 2025 | Qelbree |
| Teleflex LLC | $18.01 | 2024 | Solesta |
| Agile Therapeutics, INC. | $17.84 | 2021 | |
| Mission Pharmacal Company | $17.10 | 2023 | |
| Alydia Health | $16.16 | 2021 | |
| Olympus America INC. | $15.24 | 2024 | Olympus |
| Avion Pharmaceuticals | $13.31 | 2021 | |
| Medicem INC. | $13.19 | 2021 | |
| Amag Pharmaceuticals, INC. | $12.51 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Rittenhouse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.